Amanote Research
Register
Sign In
Lenvatinib
Cancer Control
- United States
doi 10.1177/1073274818789361
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Hematology
Date
January 1, 2018
Authors
Koichi Suyama
Hirotaka Iwase
Publisher
SAGE Publications
Related search
Treatment With Lenvatinib to Anaplastic Thyroid Cancer :
JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
Lenvatinib vs. Palliative Therapy for Stage IVC Anaplastic Thyroid Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
Administration of Lenvatinib to Patients With Anaplastic Thyroid Cancer
JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
Lenvatinib and Its Use in the Treatment of Unresectable Hepatocellular Carcinoma
Future Oncology
Medicine
Cancer Research
Oncology
Cohort Study Exploring the Effect of Lenvatinib on Differentiated Thyroid Cancer
Endocrine Journal
Endocrinology
Metabolism
Diabetes
Lenvatinib as a Novel Treatment for Anaplastic Thyroid Cancer: A Retrospective Study
Oncology Letters
Cancer Research
Oncology
Phase 2 Study of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma
Journal of Gastroenterology
Gastroenterology
Optimal Use of Lenvatinib in the Treatment of Advanced Thyroid Cancer
Cancers of the Head & Neck
Effects of Ketoconazole on the Pharmacokinetics of Lenvatinib (E7080) in Healthy Participants
Clinical Pharmacology in Drug Development
Pharmacology
Pharmaceutical Science